Phreesia Price to Book Ratio 2019-2025 | PHR

Historical price to book ratio values for Phreesia (PHR) over the last 10 years. The current price to book ratio for Phreesia as of May 01, 2025 is 5.54.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Phreesia Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2025-05-01 25.23 5.60
2025-01-31 28.46 $4.51 6.31
2024-10-31 18.29 $4.38 4.17
2024-07-31 24.95 $4.36 5.73
2024-04-30 20.74 $4.41 4.71
2024-01-31 25.48 $4.46 5.71
2023-10-31 13.66 $4.76 2.87
2023-07-31 31.72 $4.57 6.94
2023-04-30 31.64 $4.92 6.43
2023-01-31 37.49 $5.41 6.93
2022-10-31 27.32 $6.08 4.50
2022-07-31 23.49 $6.64 3.54
2022-04-30 22.88 $7.31 3.13
2022-01-31 31.19 $8.06 3.87
2021-10-31 70.54 $8.96 7.88
2021-07-31 68.35 $9.59 7.13
2021-04-30 51.75 $10.04 5.16
2021-01-31 65.29 $5.88 11.10
2020-10-31 36.97 $6.12 6.04
2020-07-31 30.06 $2.58 11.66
2020-04-30 25.39 $2.66 9.55
2020-01-31 31.00 $2.78 11.14
2019-10-31 29.63 $2.86 10.37
2019-07-31 27.33 $2.88 9.50
Sector Industry Market Cap Revenue
Medical MEDICAL INFO SYS $1.483B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) US $37.757B 52.15
Tempus AI (TEM) US $8.929B 0.00
Hims & Hers Health (HIMS) US $8.034B 129.14
Inspire Medical Systems (INSP) US $4.699B 91.27
IRhythm Technologies (IRTC) US $3.466B 0.00
Privia Health (PRVA) US $2.778B 208.18
Enovis (ENOV) US $1.976B 12.23
Schrodinger (SDGR) US $1.817B 0.00
Clover Health Investments (CLOV) US $1.696B 0.00
Omnicell (OMCL) US $1.470B 31.70
Azenta (AZTA) US $1.199B 55.81
10x Genomics (TXG) US $0.991B 0.00
Butterfly Network (BFLY) US $0.568B 0.00
Fulgent Genetics (FLGT) US $0.532B 0.00
Talkspace (TALK) US $0.527B 313.00
Veradigm (MDRX) US $0.476B 0.00
Standard BioTools (LAB) US $0.422B 0.00
TruBridge (TBRG) US $0.390B 0.00
Claritev (CTEV) US $0.360B 0.00
Health Catalyst (HCAT) US $0.280B 0.00
Nyxoah SA (NYXH) BE $0.205B 0.00
SOPHiA GENETICS SA (SOPH) CH $0.201B 0.00
Pulmonx (LUNG) US $0.152B 0.00
American Well (AMWL) US $0.097B 0.00
EUDA Health Holdings (EUDA) SG $0.091B 0.00
Retrieve Medical Holdings (RMHI) US $0.085B 0.00
MDxHealth SA (MDXH) BE $0.082B 0.00
CareCloud (CCLD) US $0.075B 3.24
111 (YI) CN $0.071B 0.00
P3 Health Partners (PIII) US $0.064B 0.00
HeartBeam (BEAT) US $0.059B 0.00
Zepp Health (ZEPP) CN $0.041B 0.00
Outset Medical (OM) US $0.040B 0.00
Zhongchao (ZCMD) CN $0.029B 0.00
ImmunoPrecise Antibodies (IPA) CA $0.021B 0.00
Bullfrog AI Holdings (BFRG) US $0.017B 0.00
MSP Recovery (MSPR) US $0.016B 0.00
Streamline Health Solutions (STRM) US $0.013B 0.00
Healthcare Triangle (HCTI) US $0.012B 0.00
Strata Skin Sciences (SSKN) US $0.011B 0.00
Predictive Oncology (POAI) US $0.010B 0.00
Precipio (PRPO) US $0.010B 0.00
Movano (MOVE) US $0.006B 0.00
Mobile-health Network Solutions (MNDR) SG $0.004B 0.00
HeartSciences (HSCS) US $0.004B 0.00
Tivic Health Systems (TIVC) US $0.003B 0.00
Future Health ESG (FHLT) US $0.000B 0.00